Anatomic heterogeneity of vascular aging - Role of nitric oxide and endothelin

被引:185
|
作者
Barton, M
Cosentino, F
Brandes, RP
Moreau, P
Shaw, S
Luscher, TF
机构
[1] UNIV HOSP BERN, DIV HYPERTENS, CH-3010 BERN, SWITZERLAND
[2] UNIV ZURICH, INST PHYSIOL, CH-8006 ZURICH, SWITZERLAND
[3] HANNOVER MED SCH, DIV CARDIOL, D-3000 HANNOVER, GERMANY
关键词
aging; endothelium; endothelins; nitric oxide; superoxide dismutase;
D O I
10.1161/01.HYP.30.4.817
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We investigated the effects of aging, a cardiovascular risk factor, on vascular function with regard to endothelial nitric oxide synthase (eNOS), superoxide dismutase (SOD), and endothelin (ET-1) in aorta and femoral artery of the rat. Concentration-response curves to acetylcholine, calcium ionophore A23187, norepinephrine, ET-1, big endothelin, sodium nitroprusside, and exogenous SOD were obtained. Expression of eNOS mRNA was analyzed by reverse-transcription polymerase chain reaction, SOD activity was assessed using a chemiluminescence-based cytochrome c assay, and ET-1 plasma concentrations were measured by radioimmunoassay. In aorta of old rats, relaxations to acetylcholine and calcium-ionophore A23157, basal NO release, and expression of eNOS mRNA in aortic endothelial cells were reduced (P<.05). In femoral arteries, relaxations to acetylcholine were preserved, whereas basal release of NO was attenuated (P<.05). Aging selectively increased contractions to norepinephrine and functional endothelin converting enzyme activity and attenuated contractions to ET-1 in aortas but not femoral arteries. Vascular SOD activity was higher in the femoral artery (P<.05) and unaffected by aging. Plasma ET-1 levels increased and plasma SOD activity decreased with age (P<.05). Aging was associated with an anatomic heterogeneity of endothelial dysfunction, functional endothelin converting enzyme activity, and vascular SOD activity. Vascular function was impaired in the aorta but not the femoral artery, which may be related to lower eNOS mRNA expression and SOD activity. These data suggest differential regulation of the vascular aging process that may contribute to the anatomic heterogeneity of atherosclerosis.
引用
收藏
页码:817 / 824
页数:8
相关论文
共 50 条
  • [21] ENDOTHELIN-1 ENHANCES NITRIC OXIDE-INDUCED CYTOTOXICITY IN VASCULAR SMOOTH-MUSCLE
    NAKAHASHI, T
    FUKUO, K
    INOUE, T
    MORIMOTO, S
    HATA, S
    YANO, M
    OGIHARA, T
    HYPERTENSION, 1995, 25 (04) : 744 - 747
  • [22] Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet
    Giardina, JB
    Green, GM
    Rinewalt, AN
    Granger, JP
    Khalil, RA
    HYPERTENSION, 2001, 37 (02) : 516 - 523
  • [23] Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats
    Mathew, R
    Zeballos, GA
    Tun, H
    Gewitz, MH
    CARDIOVASCULAR RESEARCH, 1995, 30 (05) : 739 - 746
  • [24] Erythropoietin and cerebral vascular protection: role of nitric oxide
    Santhanam, Anantha Vijay R.
    Katusic, Zvonimir S.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (11) : 1389 - 1394
  • [25] The discovery of nitric oxide and its role in vascular biology
    Moncada, S
    Higgs, EA
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 : S193 - S201
  • [26] Erythropoietin and cerebral vascular protection: role of nitric oxide
    Anantha Vijay R Santhanam
    Zvonimir S Katusic
    Acta Pharmacologica Sinica, 2006, 27 : 1389 - 1394
  • [27] Role of nitric oxide in placental vascular development and function
    Krause, B. J.
    Hanson, M. A.
    Casanello, P.
    PLACENTA, 2011, 32 (11) : 797 - 805
  • [28] Erythropoietin and cerebral vascular protection:role of nitric oxide
    Anantha VijayRSANTHANAM
    Zvonimir SKATUSIC
    Acta Pharmacologica Sinica, 2006, (11) : 1389 - 1394
  • [29] The vascular biology of nitric oxide and its role in atherogenesis
    LloydJones, DM
    Bloch, KD
    ANNUAL REVIEW OF MEDICINE, 1996, 47 : 365 - 375
  • [30] Role of vascular nitric oxide in physiological and pathological conditions
    Marin, J
    RodriguezMartinez, MA
    PHARMACOLOGY & THERAPEUTICS, 1997, 75 (02) : 111 - 134